Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Toxicol Environ Health A ; 77(7): 390-404, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24617543

RESUMEN

Manganese (Mn) is an essential element for human health. However, at high concentrations Mn may be neurotoxic. Mn accumulates in astrocytes, affecting their redox status. In view of the high antioxidant and anti-inflammatory properties of the exotic Brazilian fruit açaí (Euterpe oleracea Mart.), its methanolic extract was obtained by solid-phase extraction (SPE). This açaí extract showed considerable anthocyanins content and direct antioxidant capacity. The açaí extract scavenged 2,2-diphenyl-1-picrylhydrazyl radicals (DPPH•) with an EC50 of 19.1 ppm, showing higher antioxidant activity compared to butylated hydroxytoluene (BHT), but lower than ascorbic acid and quercetin. This obtained açaí extract also attenuated Mn-induced oxidative stress in primary cultured astrocytes. Specifically, the açaí extract at an optimal and nutritionally relevant concentration of 0.1 µg/ml prevented Mn-induced oxidative stress by (1) restoring GSH/GSSG ratio and net glutamate uptake, (2) protecting astrocytic membranes from lipid peroxidation, and (3) decreasing Mn-induced expression of erythroid 2-related factor (Nrf2) protein. A larger quantity of açaí extract exacerbated the effects of Mn on these parameters except with respect to lipid peroxidation assessed by means of F2-isoprostanes. These studies indicate that at nutritionally relevant concentration, anthocyanins obtained from açaí protect astrocytes against Mn neurotoxicity, but at high concentrations, the "pro-oxidant" effects of its constituents likely prevail. Future studies may be profitably directed at potential protective effects of açaí anthocyanins in nutraceutical formulations.


Asunto(s)
Arecaceae , Astrocitos , Suplementos Dietéticos , Manganeso , Fármacos Neuroprotectores , Estrés Oxidativo , Extractos Vegetales , Animales , Ratas , Animales Recién Nacidos , Antocianinas/efectos adversos , Antocianinas/análisis , Antocianinas/metabolismo , Arecaceae/química , Astrocitos/citología , Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Transporte Biológico/efectos de los fármacos , Brasil , Células Cultivadas , Corteza Cerebral/citología , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Suplementos Dietéticos/efectos adversos , Suplementos Dietéticos/análisis , Frutas/química , Regulación de la Expresión Génica/efectos de los fármacos , Ácido Glutámico/metabolismo , Manganeso/efectos adversos , Manganeso/química , Intoxicación por Manganeso/dietoterapia , Intoxicación por Manganeso/prevención & control , Proteínas del Tejido Nervioso/biosíntesis , Proteínas del Tejido Nervioso/metabolismo , Fármacos Neuroprotectores/efectos adversos , Fármacos Neuroprotectores/análisis , Fármacos Neuroprotectores/química , Fármacos Neuroprotectores/metabolismo , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/efectos adversos , Extractos Vegetales/química , Extractos Vegetales/metabolismo , Ratas Sprague-Dawley , Factor 2 Relacionado con NF-E2/biosíntesis , Factor 2 Relacionado con NF-E2/metabolismo
2.
Toxicol Sci ; 115(1): 194-201, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20133376

RESUMEN

Manganese (Mn) is a metal required by biological systems. However, environmental or occupational exposure to high levels of Mn can produce a neurological disorder called manganism, which has similarities to Parkinson's disease. Diethyl-2-phenyl-2-tellurophenyl vinylphosphonate (DPTVP) is an organotellurium compound with a high antioxidant activity, especially in the brain. The present study was designed to investigate the effects of long-term low-dose exposure to Mn in drinking water on behavioral and biochemical parameters in rats and to determine the effectiveness of vinylic telluride in attenuating the effects of Mn. After 4 months of treatment with MnCl(2) (13.7 mg/kg), rats exhibited clear signs of neurobehavioral toxicity, including a decrease in the number of rearings in the open field and altered motor performance in rotarod. The administration of DPTVP (0.150 micromol/kg, ip, 2 weeks) improved the motor performance of Mn-treated rats, indicating that the compound could be reverting Mn neurotoxicity. Ex vivo, we observed that Mn concentrations in the Mn-treated group were highest in the striatum, consistent with a statistically significant decrease in mitochondrial viability and [(3)H]glutamate uptake, and increased lipid peroxidation. Mn levels in the hippocampus and cortex were indistinguishable from controls, and no significant differences were noted in the ex vivo assays in these areas. Treatment with DPTVP fully reversed the biochemical parameters altered by Mn. Furthermore, DPTVP treatment was also associated with a reduction in striatal Mn levels. Our results demonstrate that DPTVP has neuroprotective activity against Mn-induced neurotoxicity, which may be attributed to its antioxidant activity and/or its effect on striatal Mn transport.


Asunto(s)
Antioxidantes/farmacología , Cloruros/efectos adversos , Compuestos de Manganeso/efectos adversos , Intoxicación por Manganeso/prevención & control , Fármacos Neuroprotectores/farmacología , Compuestos Organometálicos/farmacología , Organofosfonatos/farmacología , Telurio/farmacología , Animales , Conducta Animal/efectos de los fármacos , Cloruros/metabolismo , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/metabolismo , Exposición a Riesgos Ambientales , Masculino , Compuestos de Manganeso/metabolismo , Intoxicación por Manganeso/etiología , Intoxicación por Manganeso/fisiopatología , Actividad Motora/efectos de los fármacos , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA